UBRELVY 50 mg/1

UBRELVY 50 mg tablets contain ubrogepant, a medication used for acute migraine treatment. This oral tablet is designed to provide relief from migraine headaches. Learn more about ubrogepant and its uses.

UBRELVY 50 mg tablets are primarily used for the acute treatment of migraine headaches with or without aura in adults. Ubrogepant is a calcitonin gene-related peptide (CGRP) antagonist, which works by blocking the activity of CGRP, a molecule involved in migraine attacks. This medication is not intended for preventive use but rather for the relief of migraine symptoms once they begin.

Common effects of Ubrevly 50 mg tablets may include nausea, somnolence, and dry mouth. Some users may also experience fatigue or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

UBRELVY 50 mg tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions. Avoid driving or operating heavy machinery if you experience drowsiness. Store the medication in a cool, dry place away from direct sunlight and out of reach of children.

UBRELVY 50 mg tablets may interact with other medications, including strong CYP3A4 inducers and inhibitors. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using this medication, as it may increase the risk of side effects.